Newly on Gate2Biotech
The interview with Marek Polach - Executive Manager of CzechBio
18.2.2013 | Newly on Gate2Biotech
Czech Republic biotech and pharma industry is one of the most important in Central Europe. Nevertheless, for successful competition with the USA and Western Europe companies our regional bio-business needs to establish a platform of cooperation, which will unite companies, represent industry needs before government institutions, and further...
Patent changes - who will lose and who will gain?
14.2.2013 | Newly on Gate2Biotech
The traders who want to protect their invention or technology will have an opportunity to get a unified patent in the nearest future. The establishment of the unified patent protection will cause coexistence of four patent categories: national patents, European Patents, European Patent with Unitary Effect and European Patent with Unitary Effect...
Domainex Launches Discovery STAR Award to Support Early Academic Drug Discovery
22.1.2013 | Newly on Gate2Biotech
Domainex Ltd, specialists in drug discovery solutions and translational research support, has today announced that it is launching its Discovery STAR Award to support academic groups at the early stages of drug discovery.
PHARM Connect: Pharma and Biotech professionals of CEE getting together for further industry growth in the region
18.1.2013 | Newly on Gate2Biotech
Central and Eastern Europe is a rapidly emerging market for pharmaceutical manufacturing and distribution, and at the same time countries of the region are becoming hot-spots for research with many universities, research institutes and biotechnology companies being present.
The Student Scientific Conference on Biotechnology and Biomedicine
7.1.2013 | Newly on Gate2Biotech
Dear friends, it is our pleasure to invite you in name of Masaryk University and students organization Biomania to another year of The Student Scientific Conference on Biotechnology and Biomedicine, which will take place 10th - 12th April 2013 in the cosy environment of the main hall of the Office of the Public Defender of Rights in Brno, Czech...
Direvo validates BluZyTM technology in collaboration with US Center for Crops Utilization Research
2.1.2013 | Newly on Gate2Biotech
Direvo Industrial Biotechnology GmbH successfully completed the scale up of its first two products BluZyTM-D and BluZyTM-P in collaboration with the Center for Crops Utilization Research (CCUR) and the BioCentury Research Farm (BCRF) at Iowa State University.
Phase 2b study in Parkinson\'s disease
17.12.2012 | Newly on Gate2Biotech
Biotie's tozadenant (SYN115) meets primary and multiple secondary endpoints in phase 2b study in Parkinson's disease
OCTOPLUS convenes EGM on 15 January 2013
13.12.2012 | Newly on Gate2Biotech
With reference to the joint press releases by OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO) and Dr. Reddy's Laboratories Ltd. ("Dr. Reddy's") dated 22 October 2012 and 16 November 2012, OctoPlus today announces that it calls an Extraordinary General Meeting of Shareholders pursuant to Article 2:108a of the Dutch Civil Code...
Supergenerics - Pharma’s freshmaker!
11.12.2012 | Newly on Gate2Biotech
‘Boring’ white pills no longer do the trick from a marketing point of view. Furthermore governments and payers are looking at reducing the prices of the drugs as the way to contain costs. Additionally, margins of drugs are falling. Because of these two reasons there is a strong competition among commodity generics.
BioTek Dispensers Reach Nanoliter Levels
7.12.2012 | Newly on Gate2Biotech
December 3, 2012, WINOOSKI VT, USA — In response to increased assay miniaturization and low-volume dispensing applications, BioTek announces new lower limits for their microplate-based instruments with installed peristaltic pumps. BioTek’s EL406™ Microplate Washer Dispensers and MultiFlo™ Microplate Dispensers are capable of dispensing down to 500...
